The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Lowdell Mark William

Reporting owner CIK 0001767037 · Chief Scientific Officer

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Lowdell Mark WilliamLowdell Mark WilliamLowdell Mark William · December 1, 2025 · Stock award · Option (right to buy)Lowdell Mark William · November 18, 2025 · Stock award · Stock Option (right to buy)Lowdell Mark William · November 18, 2025 · Stock award · Stock Option (right to buy)Lowdell Mark William · November 18, 2025 · Stock award · Stock Option (right to buy)Lowdell Mark William · November 18, 2025 · Stock award · Stock Option (right to buy)Lowdell Mark William · November 18, 2025 · Stock award · Stock Option (right to buy)Nov 18, 2025Dec 1, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

6 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 1, 2025Inmune Bio, Inc.Option (right to buy)Lowdell Mark WilliamStock award
Nov 18, 2025Inmune Bio, Inc.Stock Option (right to buy)Lowdell Mark WilliamStock award
Nov 18, 2025Inmune Bio, Inc.Stock Option (right to buy)Lowdell Mark WilliamStock award
Nov 18, 2025Inmune Bio, Inc.Stock Option (right to buy)Lowdell Mark WilliamStock award
Nov 18, 2025Inmune Bio, Inc.Stock Option (right to buy)Lowdell Mark WilliamStock award
Nov 18, 2025Inmune Bio, Inc.Stock Option (right to buy)Lowdell Mark WilliamStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Inmune Bio, Inc.INMB · company listings
Lowdell Mark WilliamChief Scientific Officer
Stock awardOption (right to buy)Derivative security · Code A600,0000Value: 0Currency not specifiedView ↗
Trade: Inmune Bio, Inc.INMB · company listings
Lowdell Mark WilliamChief Scientific Officer
Stock awardStock Option (right to buy)Derivative security · Code A100,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Inmune Bio, Inc.INMB · company listings
Lowdell Mark WilliamChief Scientific Officer
Stock awardStock Option (right to buy)Derivative security · Code A140,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Inmune Bio, Inc.INMB · company listings
Lowdell Mark WilliamChief Scientific Officer
Stock awardStock Option (right to buy)Derivative security · Code A104,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Inmune Bio, Inc.INMB · company listings
Lowdell Mark WilliamChief Scientific Officer
Stock awardStock Option (right to buy)Derivative security · Code A180,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Inmune Bio, Inc.INMB · company listings
Lowdell Mark WilliamChief Scientific Officer
Stock awardStock Option (right to buy)Derivative security · Code A400,000Not reported *Value: Not reportedCurrency not specifiedView ↗